REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,431,090 | +12.4% | 9,000 | 0.0% | 0.35% | +17.8% |
Q2 2023 | $1,273,140 | -16.0% | 9,000 | 0.0% | 0.30% | -21.6% |
Q1 2023 | $1,515,240 | +99325.2% | 9,000 | 0.0% | 0.38% | -4.1% |
Q4 2022 | $1,524 | -99.9% | 9,000 | 0.0% | 0.40% | -16.3% |
Q3 2022 | $1,684,000 | +15.2% | 9,000 | 0.0% | 0.47% | +19.5% |
Q2 2022 | $1,462,000 | – | 9,000 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |